BLP treatment abolishes Treg-mediated tolerance but enhances CTL function in cancer. A, BLP treatment reduces Treg levels in tumor mice.
Using TLR agonists in cancer treatment can have either beneficial or detrimental effects. Therefore, it is important to determine.
Sep 21, 2015 · Thus, immunization with BLP effectively induced tumor-specific CTLs, so that the tumor growth was strongly inhibited. These results indicated ...
Free
CTL-Test™ Medium. Formulated for direct ex vivo testing of PBMC in cellular cytokine assays (ELISPOT, ELISA, CBA, CPA), while showing an equal or better ...
Missing: BLP | Show results with:BLP
Proposed mechanism of action of L-BLP25. APC, antigen-presenting cell; CTL, cytotoxic T lymphocyte; HLA, human leukocyte antigen; IFN-γ, interferon gamma; MPL, ...
BLPs activate the innate immune system mainly via Toll-like receptor (TLR) 2 and have been studied as a novel adjuvant for vaccines against various infectious ...
$267.00
Cat #: BLP-CT021. Type: Synthetic peptide. Form: Lyophilized Powder. CTL1 (SLC44A1) (extracellular) Blocking Peptide (#BLP-CT021) is the original antigen used ...
Missing: CTL- | Show results with:CTL-
... CTL cells and CD4+CD25+Foxp3+ Treg cells showed that BLP exerted maximal effects by upregulating CTL activity and downregulating Treg activity. That this ...
ctlblp. @ctlblp. Joined February 2020. 1 Following · 0 Followers ... @ctlblp hasn't posted. When they do, their posts will show up here.